AzTrials
AzTrials

Sedentary BehaviorACTLIFENCT04877938

ACTLIFE: is Active Life-style Enough?

A study testing Echolgical physical activity Intervention in people with Sedentary Behavior, run by Universita di Verona at 1 site in Italy.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Sedentary lifestyles in modern obesogenic society produce several dysfunctions that cause chronic diseases in lederly population and this phenomenon is becoming a major public health problem. Read more about this study

Who is it for?
Ages 65 to 99 yearsHealthy volunteers can take part
Conditions the study is for
Sedentary Behavior
What is being tested?
Echolgical physical activity Intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
180 participants
Where
1 siteItaly
Study dates
20 Jun 2021to 28 Feb 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 to 99 years
  • All sexes
  • Healthy volunteers accepted
  • Older adult

Who may be able to join

  • for sedentary individuals: ≤700 METs/week measured by IPAQ
  • for active individuals: ≥1000 METs/week measured by IPAQ

Who cannot join

  • Presence of cardiovascular and respiratory diseases
  • Presence of Hypertension
  • Presence of neurodegenerative diseases
  • Pesence of acuteor chronic conditions that might influence inlfammatory response
  • Any vascular Diabetes-related complication
  • Drugs or alchol abuse
  • Presence of other health-related condition that might affect the practice of physical activity.

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • University of Verona

    Verona, 37129

    Federico Schena, Ph.D, federico.schena@univr.it

    Massimo Venturelli, PhD, massimo.venturelli@univr.it

Other trials in Italy

About this study

Official title: ACTLIFE: is Active Life-style Enough for Health and Wellbeing in Elderly?

Sedentary lifestyles in modern obesogenic society produce several dysfunctions that cause chronic diseases in lederly population and this phenomenon is becoming a major public health problem. Regular physical activity has a profound effect on the expression of the potentials of human resilience, resulting in a decreased risk of chronic diseases. The identification of the biological mechanisms that are candidates for exercise-induced health benefits through biological pathways that are largely different from those targeted by common drugs, is highly relevant, since it might help to improve our knowledge of the pathophysiology of the chronic diseases in the sedentary population as well as to maximize the efficacy of physical activity interventions by implementing the best possible exercise dosage in older adults. For this purpose, the first aim of this project will be to identify the bioactive molecules and functional mechanisms that are candidates for exercise-induced health benefits. Moreover, in the view of more reliable, ecological and tailored approaches to counteract the problem of sedentary lifestyle, the second aim of this project will be to evaluate the effectiveness of an ecological exercise intervention in comparison to a traditional exercise intervention in sedentary elderly individuals.

Read the detailed description

The first aim of this projects will be to identify the bioactive molecules and functional mechanisms that are candidates for exercise-induced health benefits through biological pathways that are largely different from those targeted by common drugs. In the view of more reliable, ecological and tailored approaches to counteract the pandemic problem of sedentary lifestyle in elderly population, the second aim of this project will be to evaluate the effectiveness of an ecological exercise intervention (EEI) in comparison to traditional exercise intervention (TEI) in sedentary older adults.

Introduction: Despite our society has developed several advances in technology and medicine, the human genetic framework is largely tailored to support the physical activity (PA) patterns of hunter-gatherer societies living 2.5 million years ago, for which food finding was obligatorily associated to PA. The energy expenditure of hunter-gatherers (1,500 kcal/day) is similar to 3h/day of moderate-to-vigorous PA (MVPA). Contrarily, technological improvements have influenced the dramatic drop in human PA levels: 1/3 of adults worldwide are currently inactive, and the endemic inactivity trend starts in early life. Indeed, sedentary behaviors in contemporary obesogenic environments trigger dysfunctions that cause chronic diseases and this phenomenon is becoming a major public health problem. Interestingly, regular PA has a profound effect on the expression of the potentials of human resilience, resulting in numerous positive adaptations and decreased risk of chronic diseases.

Protective role of exercise on cardiovascular disease risk factors: There is strong epidemiological evidence indicating that regular PA is associated with reduced rates of cardiovascular disease (CVD), hypertension, stroke, metabolic syndrome and Type 2 diabetes. Moreover, a dose-response of PA is usually observed in the general population. It is important to note, that exercise training has an improving effect on endothelial function.

The polypill-like effect of Exercise: Despite, in the last 40 years the pandemic increase of cardio-metabolic diseases has paralleled the advances in medicine, CVD remains the leading cause of death worldwide. In this complicated scenario, Wald and Law first described a combination pill for CVD prevention, which they called a "polypill". These authors claimed that CVD could be reduced by 88% and strokes by 80% if all those over 55 years of age were given a polypill containing statin, low-dose aspirin, and folic acid. This controversial and provocative approach of "medicalizing" the population is not possible and not ethical, but polypill-like benefits are achievable with a drug-free intervention, regular PA. It is worth of mention that the identification of the bioactive molecules and biological mechanisms that are candidates for exercise-induced health benefits through biological pathways that are largely different from those targeted by common drugs, is highly relevant, since it might help to improve our knowledge of the pathophysiology of the chronic diseases in the sedentary eldely population as well as to maximize the efficacy of PA interventions by implementing the best possible exercise dosage, resulting in optimal circulating levels of "health" molecules.

The exercise polypill: Skeletal-muscle fibers can produce a plethora of secreted factors, including proteins, growth factors, cytokines, with such secretory capacity increasing during active exercise, myogenesis and muscle remodeling. Muscle-derived molecules exerting either paracrine or endocrine effects are termed "myokines" and can be consider the exercise polypill.

Since regular exercise has protective effects on cardiovascular diseases and, interestingly, it is more protective than expected based on the improvement of traditional risk factors (blood lipids, hypertension, diabetes) it is easy to speculate that additional positive effects could be mediated by myokines on targets such as adipose tissue or liver.

For example, IL-6 is probably the myokine prototype because its level increases with exercise intensity and duration. Systemic low-level inflammation is a cardinal feature of cardio-metabolic diseases, and it can be attenuated by the cumulative effect of regular exercise bouts, during which the muscle releases IL-6 which creates a healthy milieu by inducing the production of other anti-inflammatory cytokines. Another prototype of contraction-induced myokine is IL-15, with resistance exercise stimulating its secretion. Muscle-derived IL-15 is one of the mediators of the anti-obesity effects of exercise. Recent research identified a novel PGC-1 -induced myokine called iriscin. Iriscin is associated with improved aerobic fitness in cardiac patients, muscle mass, and metabolic factors in healthy people, and neurogenesis in animal models. Secreted protein acidic and rich in cysteine (SPARC) is a matricellular glycoprotein released into the bloodstream by skeletal muscle in response to aerobic exercise plays a pivotal role in adipocyte differentiation and adipose tissue turnover.

Myostatin, is a potent muscle-growth inhibitor, endurance or resistance exercise downgrade myostatin expression.

Another class of molecules which are potentially up-regulated with regular exercise and could have additional effects on the protective effects of regular exercise are neurotrophins. Among them, brain-derived neurotrophic factor (BDNF) is the most affected by exercise. Increased levels of BDNF are well documented, providing mechanistic support for a beneficial exercise effect in cognitive function. Furthermore, BDNF increases phosphorylation enhancing fatty acid oxidation and glucose utilization in skeletal muscle.The emerging general feature is that During physical inactivity, adipose tissue secretes pro-inflammatory cytokines, which can lead to development of metabolic and cardiovascular diseases, such as T2DM and atherosclerosis (Iyer et al., 2010). The study of myokines as potential biomarkers for effectiveness of exercise is an attractive approach to develop better physical protocols to apply to the elderly population.

Intervention approaches: Sedentary behaviors in older adults are strongly associated with systemic dysfunctions that cause chronic diseases and this phenomenon is becoming a major public health problem. Moreover, the recognized polypill-like effect of exercise, needs further research in order to identify the biological mechanisms that are candidates for exercise-induced health benefits. Furthermore, it is necessary to maximize the efficacy of PA interventions by implementing the best possible exercise dosage. In this complicated scenario, Owen and colleagues explain in their scientific contribution "Adults' Sedentary Behavior Determinants and Interventions" the relevant phases of the behavioral epidemiology research strategy on sedentary behavior for children and adults, highlighting several strengths of the evidence relevant to interventions and public health initiatives.

Ecological-Exercise-Intervention: One of the goals of public health interventions would be to reduce total sedentary time and also to increase the number of breaks in sedentary time. A starting point for this 'Ecological-Exercise-Intervention'(EEI), would be to limit sitting time to no more than 2 hours/day, and to stand up and move after 30 minutes of continuous sitting. In accordance with several epidemiologic evidences light-intensity activities would be encouraged to substitute sedentary time (e.g., standing up while talking on the telephone, ironing while watching TV). Taking into consideration the guidance provided by ecologic models of health behavior evidences about specific constructs to guide EEI may be derived from behavioral research on physical activity. However, further studies are needed to clarify the feasibility, acceptability, and effectiveness of EEI in young and adult populations. On this matter, promising results have been observed in studies targeting increases in daily walking. Moreover, systematic evaluations of these "natural approaches" could be highly informative, especially through assessing whether changes in sedentary time actually do result.

Being tested
Echolgical physical activity Intervention
Keywords
Physical Activity, Echological Intevention, Older Adults
Medical subject headings
Sedentary Behavior, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Echolgical physical activity InterventionBehavioural

    'Ecological-Exercise-Intervention'(EEI), would be to limit sitting time to no more than 2 hours/day, and to stand up and move after 30 minutes of continuous sitting. In accordance with several epidemiologic evidences light-intensity activities would be encouraged to substitute sedentary time (e.g., standing up while talking on the telephone, ironing while watching TV).

Study groups in NCT04877938
Study groupRoleWhat they receive
Echological InterventionExperimentalA starting point for this 'Ecological-Exercise-Intervention'(EEI), would be to limit sitting time to no more than 2 hours/day, and to stand up and move after 30 minutes of continuous sitting. In accordance with several epidemiologic evidences light-intensity activities would be encouraged to substitute sedentary time (e.g., standing up while talking on the telephone, ironing while watching TV). Taking into consideration the guidance provided by ecologic models of health behavior evidences about specific constructs to guide EEI may be derived from behavioral research on physical activity.
Receives: Behavioral: Echolgical physical activity Intervention
Standard Physical Activity InterventionActive comparatorPeople included in this group will be assigned to a standard physical activity program that will follow the guidelines of the American College of Sport and Medicine. The program will include moderate intensity aerobic and strength training, three times a week for a total amunt of 200 min of physical activity/week.
Receives: Behavioral: Echolgical physical activity Intervention
Control groupNo interventionIndividuals included in this group will be asked to keep their life style,without taking part in any physical activity program.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Measure of strandars healthy-related biochemical parameters

    Blood samples will be collected two times: 1) between 7:00 and 9:00 am, following overnight fasting, 48h distant from the last exercise session and 2) immediately after a training session. After centrifugation, they will be divided in different aliquots of appropriate amount and stored a -80°C in order to: measure triglycerides, total cholesterol, blood glucose, aspartate transaminase, alanine transaminase, creatinine

    Measured: through study completion, an average of 8 months

Secondary outcomes (9)
  1. Measure of Daily Energy Expenditure

    Each participant will be outfitted with an Actiheart device allowing heart rate and acceleration data to be simultaneously recorded 24 hours a day for 7 consecutive days.

    Health-related quality of life: The Italian version of the SF-36 health survey will be administrated before and after the interventions.

    Measured: through study completion, an average of 8 months

  2. Measure of the appendicular muscle mass

    Magnetic resonance imaging (MRI) will be performed using a 1.5 Tesla MRI system. T1-weighted images of the lower limbs will be acquired supine with the legs extended. On the basis of a signal-intensity threshold, muscle borders will be selected to delineate and differentiate muscle, fat, and connective tissue. In the thighs area, the vastus lateralis (VL), vastus medialis, vastus intermedius, and rectus femoris will be traced in each image and in combination made up the quadriceps. Quadriceps muscle volumes will be calculated by summing the areas of all the slices.

    Measured: through study completion, an average of 8 months

  3. Measure of Musle architecture

    In the thigh, sagittal ultrasound images of the VL muscle will be recorded with a GE ultrasound system (GE Logiq-7) equipped with an 8-12 MHz linear transducer. Images will be obtained with a 90° flexion of hip and knee, at 50% of femur length corresponding to the mid-belly of the VL muscle. The pennation angle of the VL fascicles will be measured as the angle between the VL muscle fascicles and the deep aponeurosis of the insertion.

    Measured: through study completion, an average of 8 months

  4. Measure of systemic vascular function

    The passive limb movement protocol consisted of 60 s of resting baseline femoral blood flow data collection, followed by 60 s of passive knee extension and flexion with the same measure. Blood velocity will be analyzed with 1 Hz resolution on the Doppler ultrasound system (GE Logiq-7) for 60 s at rest and second by second for the first 60 s following the initiation of PLM.

    Measured: through study completion, an average of 8 months

  5. Measure of cirulating level of hormones

    Blood samples will be collected two times: 1) between 7:00 and 9:00 am, following overnight fasting, 48h distant from the last exercise session and 2) immediately after a training session. After centrifugation, they will be divided in different aliquots of appropriate amount and stored a -80°C in order to: measure cirulatin glevels of hormones such as: GH, IGF-1, IGFBP3, insulin and cortisol; the pro- and anti-inflammatory markers, C Reactive Protein (CRP), IL-1, IL-6 and IL-1ra; and of the sex-hormones testosterone, oestradiol, oestrone and sex hormone-binding globulin (SHBG);

    Measured: through study completion, an average of 8 months

  6. Measure of cirulating bioactive markers

    Blood samples will be collected two times: 1) between 7:00 and 9:00 am, following overnight fasting, 48h distant from the last exercise session and 2) immediately after a training session. After centrifugation, they will be divided in different aliquots of appropriate amount and stored a -80°C in order to measure circulating miRNA, PGC-1, Myonectin, Musclin, Sparc, Myostatin, BDNF, VEGF, and BDNF

    Measured: through study completion, an average of 8 months

  7. Measure of cardio-metabolid health

    Measurements of blood pressure will be performed with standard auscultatory and mercury sphygmomanometer technique.

    From a fasted venous blood sample Glucose, high- and low-density lipoprotein will be measured on a Cobas c501 (Roche Diagnostics GmbH, Mannheim, Germany), using proprietary reagents.

    Body anthropometrics will be measured with a standard protocol: body mass, height, body mass index calculation (BMI = body mass / height2), percent of body fat (7 skinfolds approach), waist and hip circumferences.

    Measured: through study completion, an average of 8 months

  8. Measure of exercise capacity

    To determine exercise capacity the subjects will perform an incremental walking maximal exercise trial (rest, 25%, 50%, 75%, and 100% of maximal exercise capacity). Breath-by-breath O2 expiratory airflow will be continuously recorded at rest, and during the exercise trial.

    Measured: through study completion, an average of 8 months

  9. Measure of Lower limbs neuromuscular control

    The force and EMG envelope rate of development during a maximum voluntary contraction and a tetanic stimulation will be compared in order to estimate the role of central command flow to the muscle in changing the efficiency of the tension development at the tendon. The maximal voluntary contraction will be started after a visual command will be done.

    Measured: through study completion, an average of 8 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 May 2021
  2. Study start20 Jun 2021 (estimated)
  3. Primary completion30 Jun 2022 (estimated)
  4. Study completion28 Feb 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
1 group echological intervention 1 group standard physical activity intervention 1 control group
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
180 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04877938
Sponsor's protocol ID
PRIN 2017
Acronym
ACTLIFE
Status last verified
May 2021
First submitted
16 Nov 2020
Last updated
7 May 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Fiuza-Luces C, Garatachea N, Berger NA & Lucia A. (2013). Exercise is the real polypill. Physiology (Bethesda) 28, 330-358. Gilson ND, Ainsworth B, Biddle S, Faulkner G, Murphy MH, Niven A, Pringle A, Puig-Ribera A, Stathi A & Umstattd MR. (2009a). A multi-site comparison of environmental characteristics to support workplace walking. Prev Med 49, 21-23. Gilson ND, Puig-Ribera A, McKenna J, Brown WJ, Burton NW & Cooke CB. (2009b). Do walking strategies to increase physical activity reduce reported sitting in workplaces: a randomized control trial. Int J Behav Nutr Phys Act 6, 43. Iyer A, Fairlie DP, Prins JB, Hammock BD & Brown L. (2010). Inflammatory lipid mediators in adipocyte function and obesity. Nat Rev Endocrinol 6, 71-82. Joyner MJ & Green DJ. (2009). Exercise protects the cardiovascular system: effects beyond traditional risk factors. J Physiol 587, 5551-5558. Knaepen K, Goekint M, Heyman EM & Meeusen R. (2010). Neuroplasticity - exercise-induced response of peripheral brain-derived neurotrophic factor: a systematic review of experimental studies in human subjects. Sports Med 40, 765-801. Louis E, Raue U, Yang Y, Jemiolo B & Trappe S. (2007). Time course of proteolytic, cytokine, and myostatin gene expression after acute exercise in human skeletal muscle. J Appl Physiol (1985) 103, 1744-1751. Matthews CE, George SM, Moore SC, Bowles HR, Blair A, Park Y, Troiano RP, Hollenbeck A & Schatzkin A. (2012). Amount of time spent in sedentary behaviors and cause-specific mortality in US adults. Am J Clin Nutr 95, 437-445. Owen N, Sugiyama T, Eakin EE, Gardiner PA, Tremblay MS & Sallis JF. (2011). Adults' sedentary behavior determinants and interventions. Am J Prev Med 41, 189-196. Riechman SE, Balasekaran G, Roth SM & Ferrell RE. (2004). Association of interleukin-15 protein and interleukin-15 receptor genetic variation with resistance exercise training responses. J Appl Physiol (1985) 97, 2214-2219. Sallis JF, Cervero RB, Ascher W, Henderson KA, Kraft MK & Kerr J. (2006). An ecological approach to creating active living communities. Annu Rev Public Health 27, 297-322. Venturelli M, Pedrinolla A, Boscolo Galazzo I, Fonte C, Smania N, Tamburin S, Muti E, Crispoltoni L, Stabile A, Pistilli A, Rende M, Pizzini FB & Schena F. (2018). Impact of Nitric Oxide Bioavailability on the Progressive Cerebral and Peripheral Circulatory Impairments During Aging and Alzheimer's Disease. Frontiers in Physiology 9. Wald NJ & Law MR. (2003). A strategy to reduce cardiovascular disease by more than 80%. BMJ 326, 1419. Walther C, Gaede L, Adams V, Gelbrich G, Leichtle A, Erbs S, Sonnabend M, Fikenzer K, Korner A, Kiess W, Bruegel M, Thiery J & Schuler G. (2009). Effect of increased exercise in school children on physical fitness and endothelial progenitor cells: a prospective randomized trial. Circulation 120, 2251-2259.

Questions about this trial

What is this clinical trial studying?

A study testing Echolgical physical activity Intervention in people with Sedentary Behavior, run by Universita di Verona at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 7 May 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Federico Schena, PhD (0458415143 ext. 0039, federico.schena@univr.it), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Measure of strandars healthy-related biochemical parameters (time frame: through study completion, an average of 8 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04877938, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 May 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in